Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Preliminary clinical safety of the recombinant gag-env HIV-1 protein-based vaccine VICHREPOL shown

July 25, 2007

Results from Samaritan's phase IIb study of novel HIV entry inhibitor

July 25, 2007

Profectus receives grant to develop anti-HIV antibodies

July 25, 2007

Abbott submits regulatory filings for lower-strength Kaletra/Aluvia tablet

July 24, 2007

Celsentri recommended for approval in E.U.

July 23, 2007

Roche and Trimeris begin integrase inhibitor and once-daily Fuzeon combination trial

July 23, 2007

GeoVax begins two new AIDS vaccine clinical trials

July 23, 2007

NDA submission for TMC-125

July 20, 2007

Orchestra Therapeutics discontinues HIV vaccine development program

July 20, 2007

Recent Incyte patent reports novel agents for HIV infection

July 19, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 7, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...